A panel of advisors to the FDA voted against the potential use of MDMA for treating PTSD.
A dose of MDMA. The drug has been studied as a treatment for PTSD and FDA is now considering whether to approve it.
However, that would be especially surprising given the host of concerns raised during the all-day meeting. “We are charting new territory,” said Kim Witczak, a consumer representative on the FDA’s advisory committee. “We want to set it up right.” “Although we do have two positive studies, the results are in the context of dramatic functional unblinding,” says Dr. David Millis, clinical reviewer for the FDA.
While not yet published in a peer-reviewed journal, that data “suggest evidence of MDMA’s durability to at least six months,” said Yazar-Klosinski with Lykos.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA panel to consider psychedelic party drug MDMA, or molly, for PTSDThe FDA's panel of independent advisers will on June 4 deliberate whether to recommend approval for the first MDMA-assisted therapy for PTSD, Lykos Therapeutics said.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDFederal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD.
Read more »
Psychedelic drug MDMA faces questions as FDA considers approval for PTSDThe drug application is part of a decade-long effort by advocates to move psychedelic drugs into the medical mainstream.
Read more »